Study: DTC ads for breast cancer drugs hit target

11/26/2012 | Medical Marketing & Media

Direct-to-consumer campaigns for three aromatase inhibitors did not spur more prescriptions for premenopausal breast cancer patients but may have increased prescriptions for postmenopausal patients, for whom the drugs are indicated, a study published in the journal Cancer found.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX